The Scientist - Spotlight on Epigenetics Drug Discovery sponsored exclusively by Rockland Immunochemicals.
• Do we have a good understanding of the mechanisms underlying epigenetics?
• Do we have the right in vitro assays, screening platforms, and in vivo models?
• How do we tackle the concerns about safety and adverse events?
• Case studies highlighting current challenges and opportunities
Find out more on Wednesday, June 25, 2014 2:30–4:00 PM ET
MARGARET PORTER-SCOTT, PhD, Senior Director, Lead Discovery, Epizyme Inc.
JATINDER SINGH, PhD, Principal Scientist, Drug Safety and Metabolism, AstraZeneca Pharmaceuticals